Literature DB >> 11764285

Histochemical and immunohistochemical markers for human eccrine and apocrine sweat glands: an aid for histopathologic differentiation of sweat gland tumors.

K Saga1.   

Abstract

Apocrine and eccrine sweat glands are distinct in function, although they are closely related to each other developmentally and morphologically. In certain sweat gland tumors, it is difficult to differentiate between eccrine or apocrine sweat glands. Therefore, this paper reviews histochemical and immunohistochemical markers to differentiate apocrine and eccrine sweat glands with the aim of better understanding the structural and functional characteristics of these sweat glands. Specific markers for apocrine sweat glands are as follows: neuraminidase sensitive anionic sites detected by cationic colloidal gold at pH 2.0, and mitochondrion-like secretory granules that have epidermal growth factor-like antigenicity. The following antibodies react with apocrine sweat glands but not with eccrine sweat glands; the antibodies raised against 70 kDa glycoprotein purified from human milk fat globule membranes, and HMFG-1 (1.10.F3) monoclonal antibody produced by immunizing mice with defatted human milk fat globule membranes. Markers for eccrine sweat glands are as follows: dark cell granules that have chondroitinase ABC sensitive anionic sites detected by cationic gold at pH 2.0 after pretreatment with EGTA, and intercellular canaliculi with high activity of alkaline phosphatase. CEA and GCDFP-15 are expressed in both eccrine and apocrine sweat glands. Anti-EMA monoclonal antibody (E29) stains both eccrine and apocrine sweat glands.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11764285     DOI: 10.1046/j.0022-202x.2001.00005.x

Source DB:  PubMed          Journal:  J Investig Dermatol Symp Proc        ISSN: 1087-0024


  8 in total

1.  The stem cell marker CD133 (Prominin-1) is expressed in various human glandular epithelia.

Authors:  Jana Karbanová; Ewa Missol-Kolka; Ana-Violeta Fonseca; Christoph Lorra; Peggy Janich; Hana Hollerová; József Jászai; Jirí Ehrmann; Zdenek Kolár; Cornelia Liebers; Stefanie Arl; Danuse Subrtová; Daniel Freund; Jaroslav Mokry; Wieland B Huttner; Denis Corbeil
Journal:  J Histochem Cytochem       Date:  2008-07-21       Impact factor: 2.479

2.  Fine-needle aspiration cytology of eccrine hidrocystoma.

Authors:  Shelly Sehgal; Reena Agarwal; Sompal Singh; Prashant Goyal
Journal:  Cytojournal       Date:  2012-02-24       Impact factor: 2.091

Review 3.  Fibroepithelioma of Pinkus Revisited.

Authors:  Ellen S Haddock; Philip R Cohen
Journal:  Dermatol Ther (Heidelb)       Date:  2016-06-21

4.  Pleomorphic Adenoma of the Eyelid with Apocrine Gland Origin; an Atypical Location.

Authors:  Renata T Rothwell; Sofia B Campelos; Sandra Prazeres
Journal:  J Ophthalmic Vis Res       Date:  2016 Oct-Dec

5.  Mixed tumour of the skin of the lower lip: A case report and review of the literature.

Authors:  Shimpei Gotoh; Edward H Ntege; Toshiyuki Nakasone; Akira Matayoshi; Sho Miyamoto; Yusuke Shimizu; Hiroyuki Nakamura
Journal:  Mol Clin Oncol       Date:  2022-01-24

6.  Gross cystic disease fluid protein 15 in stratum corneum is a potential marker of decreased eccrine sweating for atopic dermatitis.

Authors:  Koji Kamiya; Jun-Ichi Sakabe; Hayato Yamaguchi; Takahiro Suzuki; Tsuyoshi Yatagai; Masahiro Aoshima; Taisuke Ito; Yoshiki Tokura
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240

7.  MUC-1 expression in pleomorphic adenomas using two human milk fat globule protein membrane antibodies (HMFG-1 and HMFG-2).

Authors:  Santa Ponce-Bravo; Constantino Ledesma-Montes; Maricela Garcés-Ortíz
Journal:  J Appl Oral Sci       Date:  2015 May-Jun       Impact factor: 2.698

8.  Reactive Eccrine Syringofibroadenomatosis Presenting as Bilateral Plantar Hyperkeratosis.

Authors:  Nidhi Singh; Laxmisha Chandrashekar; Pragasam Shakthi; Devinder Mohan Thappa; Bhawana Ashok Badhe; Mary Theresa Sylvia
Journal:  Indian J Dermatol       Date:  2015 Jul-Aug       Impact factor: 1.494

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.